What is the management of papillary necrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Renal Papillary Necrosis

The management of renal papillary necrosis requires prompt identification of the underlying cause, appropriate imaging studies, and a combination of medical and possibly surgical interventions based on severity and complications.

Etiology and Risk Factors

Renal papillary necrosis (RPN) is characterized by ischemic necrobiosis of the renal papillae in the medulla. Common risk factors include:

  • Diabetes mellitus
  • Analgesic abuse/overuse (NSAIDs)
  • Urinary tract infections
  • Urinary tract obstruction
  • Sickle cell disease
  • Pyelonephritis
  • Renal vein thrombosis
  • Tuberculosis

Multiple risk factors are often present simultaneously, with two or more identified in approximately 36% of patients 1.

Diagnostic Approach

Imaging Studies

  • CT scan is the preferred imaging modality for diagnosis of RPN, offering superior visualization compared to other techniques 2, 3. Multi-detector row CT provides clearer images with thinner sections and multiplanar reformation capabilities.

  • Characteristic CT findings include:

    • Contrast-filled clefts in the renal medulla
    • Non-enhanced lesions surrounded by rings of excreted contrast material ("ring shadows")
    • Hyperattenuated medullary calcifications
    • Blunted papillary tips
    • Hydronephrosis in cases of papillary sloughing
    • Filling defects in the renal pelvis or ureter 3, 4
  • Intravenous urography has been traditionally used but may be difficult in patients with poor renal function 4.

  • Retrograde pyelography can be considered in pediatric cases to minimize radiation exposure 5.

Management Approach

1. Identify and Treat Underlying Cause

  • Discontinue nephrotoxic medications: If analgesic abuse is identified, immediately stop all NSAIDs 6. Patients at high risk for renal toxicities include those over 60 years, those with compromised fluid status, and those on concomitant nephrotoxic drugs.

  • Control diabetes: Optimize glycemic control in diabetic patients.

  • Treat infections: Administer appropriate antibiotics for urinary tract infections or pyelonephritis.

  • Address sickle cell disease: Appropriate management of the underlying hematologic condition.

  • Relieve obstruction: If urinary tract obstruction is present, prompt intervention is necessary.

2. Medical Management

  • Fluid management: Ensure adequate hydration to maintain good urine flow.

  • Pain control: Use non-NSAID analgesics for pain management.

  • Monitor renal function: Regular assessment of BUN, creatinine, and electrolytes.

  • Antibiotics: For associated infections or as prophylaxis in recurrent cases.

3. Surgical Management

  • Indicated for complications such as:

    • Obstructive uropathy from sloughed papillae
    • Persistent hematuria
    • Recurrent infections
    • Formation of a fungus ball
  • Surgical options include:

    • Removal of obstructing sloughed papillae
    • Drainage of abscesses
    • In severe cases with renal failure, dialysis may be necessary

Follow-up and Monitoring

  • Regular monitoring of renal function
  • Surveillance imaging to assess progression or resolution
  • Long-term follow-up as the risk for requiring renal replacement therapy after diagnosis is approximately 7% 1

Prognosis

The prognosis varies depending on the underlying cause:

  • Ten-year survival for non-diabetic patients with RPN is not significantly different from age and sex-matched controls 1
  • Diabetic patients with RPN have the lowest survival rates 1
  • Early diagnosis and treatment can prevent progression to end-stage renal disease

Special Considerations

  • In patients being evaluated as potential kidney donors, incidental finding of RPN should prompt reconsideration of donor candidacy 2
  • In pediatric patients with sickle cell disease presenting with hematuria, RPN should be considered in the differential diagnosis 5

Early recognition and appropriate management of renal papillary necrosis are crucial to prevent progression of renal damage and improve outcomes.

References

Research

Renal papillary necrosis--a sixteen-year clinical experience.

Journal of the American Society of Nephrology : JASN, 1995

Research

Renal Papillary Necrosis: Role of Radiology.

Journal of clinical and diagnostic research : JCDR, 2016

Research

Renal papillary necrosis: review and comparison of findings at multi-detector row CT and intravenous urography.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.